Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial

Alexis R. Freedland, Daniel M. Moriera, Jun Gong, Stephen J. Freedland
Prostate · Wiley · 2026-11-14 · DOI: 10.1002/pros.70241

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles